…Low-dose topiramate appears to be as effective as the atypical antipsychotic agent risperidone in controlling behavioural disturbances in AD patients, according to the results of a double-blind trial (Mowla & Pani. J Clin Psychopharmacol 2010; 30: 40-43). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…the newsletter with Continue…
…Combination therapy may be an effective approach in patients with psychotic depression, according to the results of the STOP-PD trial (Meyers et al. Arch Gen Psychiatry 2009; 66: 838-847). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…The SADHART (Sertraline Antidepressant Heart Attack Randomized Trial) study was a placebo-controlled trial of the SSRI sertraline in 369 patients with acute coronary syndrome who met diagnostic criteria for major depression (Glassman et al. Arch Gen Psychiatry 2009; 66: 102-1029). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
View commentary by Daniel Selchen, MD Following news reports last fall of a possible cure for MS, clinicians and MS Societies worldwide have been inundated with inquiries about the new procedure. Its originator, Dr. Paulo Zamboni of Ferrara, Italy, has reported that a condition that he calls chronic cerebrospinal venous insufficiency (CCSVI) is the underlying problem in multiple sclerosis. Subscribe to read more It takes 30 seconds or login using…